Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for treating nerve damage rather than only suppressing inflammation.

A cross-section of the spinal cord showing neurons and glial cells. (Juan Carlos Juarez Jaramillo/iStock/Getty Images Plus) A ...

As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...

A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...

BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday morning — making the step forward toward finding a cure for multiple ...

If you’ve been recently diagnosed with SPMS, you may wonder how the transition between RRMS and SPMS will affect your MS treatment options and lifestyle. Most people with MS are initially diagnosed ...

Multiple sclerosis is an autoimmune condition that affects the nervous system, leading to nerve damage and chronic inflammation. While the exact cause of this disorder is unknown, experts believe ...

Early diagnosis of MS can lead to better management and treatment of the condition. Multiple sclerosis is a chronic disease that affects the central nervous system and is caused by damage to the ...

After months of mysterious symptoms, I heard the words “multiple sclerosis.” Now that I know what I’m dealing with, I can ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...